Cargando…

Multiple Myeloma (Part 1) – Update on Epidemiology, Diagnostic Criteria, Systemic Treatment and Prognosis

Multiple myeloma (MM) is a hematological malignancy characterized by unregulated and clonal proliferation of plasma cells in the bone marrow; these cells produce and secrete an anomalous monoclonal immunoglobulin, or a fragment of this, called M protein. The clinical manifestations of MM result from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guedes, Alex, Becker, Ricardo Gehrke, Teixeira, Luiz Eduardo Moreira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310414/ https://www.ncbi.nlm.nih.gov/pubmed/37396092 http://dx.doi.org/10.1055/s-0043-1770149

Ejemplares similares

Multiple Myeloma (Part 2) - Update on The Approach to Bone Disease
por: Guedes, Alex, et al.
Publicado: (2023)

Epidemiology of multiple myeloma in 17 Latin American countries: an update
por: Curado, Maria Paula, et al.
Publicado: (2018)

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
por: Lakshman, Arjun, et al.
Publicado: (2018)

Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices
por: Chou, I-Jun, et al.
Publicado: (2016)

Criteria for Identification of Homogeneous Electrophoretic Peaks in Multiple Myeloma
por: Conn, Harold O., et al.
Publicado: (1962)

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021)

Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party
por: Jung, Sung-Hoon, et al.
Publicado: (2022)

Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()
por: Magalhães, Geraldo Magela, et al.
Publicado: (2021)

P08 TEMPORAL TRENDS IN PROGNOSIS OF PATIENTS WITH SMOLDERING MULTIPLE MYELOMA (SMM) WHO MEET CRITERIA FOR BIOMARKER-DEFINED EARLY MULTIPLE MYELOMA (SLIM CRAB POSITIVE MM)
por: Ludwig, H., et al.
Publicado: (2023)

Epidemiology, Staging, and Management of Multiple Myeloma
por: Padala, Sandeep Anand, et al.
Publicado: (2021)

Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup
por: Wiedmeier-Nutor, Julia Erin, et al.
Publicado: (2022)

PB2085: EPIDEMIOLOGICAL DESCRIPTION AND PROGNOSIS FEATURES OF MULTIPLE MYELOMA IN A TUNISIAN HAEMATOLOGY CENTER
por: Boughanmi, Sarah, et al.
Publicado: (2023)

Vascular dementia: Diagnostic criteria and supplementary exams. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part I
por: Engelhardt, Eliasz, et al.
Publicado: (2011)

Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
por: Abramson, Hanley N.
Publicado: (2018)

Pain Management in Patients with Multiple Myeloma: An Update
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Analysis of Updates in Multiple Myeloma Treatment and Management
por: Nieto, Maria Jacqueline, et al.
Publicado: (2023)

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma
por: Ravi, Praful, et al.
Publicado: (2018)

Retrospective evaluation of the use of the International Myeloma Working Group response criteria in dogs with secretory multiple myeloma
por: Moore, A Russell, et al.
Publicado: (2020)

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
por: Zerr, I., et al.
Publicado: (2009)

Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk
por: Di Pino, Antonino, et al.
Publicado: (2016)

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions
por: Yamada, Masahito, et al.
Publicado: (2020)

Update of the diagnostic criteria of brain death: application and training of physicians
por: Chehuen Neto, José Antonio, et al.
Publicado: (2019)

Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China
por: Cai, Meng-Ting, et al.
Publicado: (2022)

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
por: Polman, Chris H, et al.
Publicado: (2011)

SLiM CRAB criteria revisited: temporal trends in prognosis of patients with smoldering multiple myeloma who meet the definition of ‘biomarker-defined early multiple myeloma’—a systematic review with meta-analysis
por: Ludwig, Heinz, et al.
Publicado: (2023)

Update on the optimal use of bortezomib in the treatment of multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2017)

Recent updates on CAR T clinical trials for multiple myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Large Epidemiologic Studies of Gout: Challenges in Diagnosis and Diagnostic Criteria
por: Wijnands, José M. A., et al.
Publicado: (2010)

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
por: Tesfaye, Solomon, et al.
Publicado: (2010)

Impact of updated international diagnostic criteria for the diagnosis of polycystic ovary syndrome
por: Kostroun, Katherine E., et al.
Publicado: (2022)

Epidemiology of multiple myeloma in Poland in the years 2008–2017
por: Waszczuk-Gajda, Anna, et al.
Publicado: (2020)

Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma
por: Lee, N, et al.
Publicado: (2017)

Diagnostic and Prognostic Value of PACAP in Multiple Myeloma
por: Tóth, Tünde, et al.
Publicado: (2023)

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review
por: Nishida, Hiroko
Publicado: (2021)

Changing Malaria Epidemiology and Diagnostic Criteria for Plasmodium falciparum Clinical Malaria
por: Roucher, Clémentine, et al.
Publicado: (2012)

Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
por: Narita, Kentaro, et al.
Publicado: (2021)

PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA.
por: Pérez, Ernesto, et al.
Publicado: (2023)

Updating the diagnostic criteria of COVID-19 “suspected case” and “confirmed case” is necessary
por: Wang, Yun-Yun, et al.
Publicado: (2020)

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
por: Valent, Peter, et al.
Publicado: (2021)

Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma
por: Parrondo, Ricardo D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r5ufo4bp3r870hn4u52t6feku8